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I. INTRODUCTION
Serine hydroxymethyltransferase, SHMT, is a vital enzyme involved in the
biosynthesis of pyrimidine nucleotides. SHMT is a pyridoxyl-5’-phosphate (PLP)dependent enzyme and it generates one-carbon fragments for the biosynthesis of small
molecules such as purines, thymidylate, methionine, and choline (Schirch, 2005). The
enzyme catalyzes the
tetrahydrofolate-dependent
conversion of serine to glycine.
Geometric structural studies have
Figure 1: Proposed mechanism of SHMT catalyzing the tetrahydrofolatedependent conversion of serine to glycine (Schirch, 2005).

led to a proposed retroaldol

mechanism of this conversion (Figure 1), which involves a nucleophilic attack by N5 of
tetrahydrofolate on serine C3 breaking the C3—C2bond of serine (Schirch, 2005).
The enzyme is part of the thymidylate
synthase cycle (Figure 2), which generates
nucleotides needed for DNA synthesis of growing
cells. SHMT converts serine and tetrahydrofolate
to glycine and N5, N10-methylenetetrahydofolate. A
one-carbon unit from N5, N10methylenetetrahydrofolate is transferred to
deoxyuridine monophosphate, dUMP, to produce
thymidylate, dTMP (Lehninger).

Figure 2. Thymidylate Synthase Cycle showing
the production of thymidylate, dTMP (Lehninger).

During the S Phase of the cell cycle, DNA is replicated to produce a second copy
of the DNA,

one for each daughter cell. The enzyme that synthesizes DNA, DNA

polymerase, uses deoxynucleotides to produce a copy of the original DNA template
strand. The four deoxynucleotides used for DNA synthesis include deoxycytidylate,
deoxyadenylate, deoxyguanylate, and thymidylate (Lehninger). If a cell is incapable of
copying its DNA, it is unable to divide. Since SHMT is needed for the biosynthesis of
thymidylate, it suggests that inhibitors of SHMT could potentially serve as anticancer
drugs in prohibiting the growth of cancer cells.
Extensive research has gone into the other two enzymes in the thymidylate
synthase cycle, dihydrofolate reductase (DHFR) and thymidylate synthase (TS), as
possible anticancer targets. Methotrexate is an anticancer antifolate drug from the 1950s
that targets DHFR (McGuire, 2003). Methotrexate is still used today, and because of its
utility and safety, attention has been put into finding more anticancer antifolates
(McGuire, 2003). A recent study showed how 2-hydroxyoleic acid (HOA) repressed the
expression of DHFR. When cancer cells were treated with HOA, cell cycle arrest or
apoptosis resulted, most likely from the impairment of DNA synthesis (Llado, 2009). A
lot of attention has also been paid to inhibitors of thymidylate synthase. Fluorouracil is a
chemotherapy drug that inhibits thymidylate synthase. It has been around for a few
decades and its primary use is a chemotherapy agent for colorectal and pancreatic cancer.
A recent finding showed how histone deacetylase inhibitors significantly down regulate
thymidylate synthase gene expression in colon cancer cells (Fazzone, 2009). Several
studies have been conducted to find inhibitors of DHFR and TS but little effort has been
invested in SHMT.

In order to characterize the
activity and other properties of SHMT, it

Figure 3. Arabinose binds to the repressor, allowing RNA
Polymerase to attach to the Operator so that gene expression
of SHMT can begin.

first has to be overexpressed and purified from E. coli. A particular colony of E. coli
cells, SHMT SL75 BL21, contains a plasmid which encodes for the human SHMT gene.
For the gene to be expressed, its DNA sequence has to be copied through the process of
transcription. A repressor protein is bound to the DNA to block RNA polymerase from
binding to the DNA strand and transcribing mRNA. An inducer is needed to bind to the
repressor, causing a conformational change in the repressor so that it leaves the DNA
strand. Arabinose is a five carbon monosaccharide that acts as an inducer, allowing for
the start of SHMT gene expression (Wikipedia).
To purify the enzyme, two techniques are used; protein precipitation and fast
protein liquid chromatography (FPLC). Protein precipitation, or “salting out”, is a
common method used to separate proteins based on their solubility. The addition of a
neutral salt, such as ammonium sulfate, increases the salt concentration of a solution.
This causes the water to interact more with the salt ions and less with the solvation layer
around the proteins. The proteins that express hydrophobic patches aggregate with each
other and precipitate out of solution.
FPLC is used to purify SHMT by ion exchange. The isoelectric point, pI, of a
protein is the pH where the enzyme has no net electrical charge. At a pH below the

protein’s pI, it will carry a net positive charge and will bind to a negatively charged
column whereas negatively charged proteins will not bind. SHMT has a pI of about 8.3
(Nirmalan, 2007). A pH of about 7.9 is used for the FPLC column so that SHMT will
have a net positive charge. The protein will be eluted by changing the ionic strength of
the column.
After fractions are collected from FPLC, the activity of SHMT in each fraction
can be traced by absorbance spectroscopy. SHMT from other sources has been known to
catalyze a side reaction of allo-threonine to acetaldehyde. The enzyme alcohol
dehydrogenase then converts acetaldehyde and NADH to ethanol and NAD+. NADH has
a strong absorbance at 340nm so when it’s oxidized to NAD+, the absorbance decreases
over time.

II. METHODS AND MATERIALS
Small Scale Overexpression
Overnight cultures were prepared with LB, 0.034mg/mL chloramphenicol
(CAM), 0.05mg/mL ampicillin (AMP), and SHMT BL21 SL75 cells. The cultures
incubated on a shaker overnight at 37˚C. Flasks containing LB, CAM, and AMP were
inoculated with 1mL of the overnight culture. The flasks were placed on a shaker at 37˚C
and the absorbance of the cultures was measured periodically using the Ocean Optics
Spectrophotometer at 600nm. When the OD600 reached 0.6, an inducer was added to the
flask; either 1mM IPTG or various concentrations of arabinose, ranging from 0.002% to
1%. The cells were placed on a shaker at 37˚C for four hours. The cultures were
centrifuged for fifteen minutes at 3200rpm, the supernatant was poured off, and the cells
were stored in the -80˚C freezer until purification.

Purification Prep
The cells were removed from the -80˚C freezer and thawed over ice. They were
resuspended in cold Tris pH 7.4 buffer with 0.5mg/mL lysozyme. The cells were
sonicated while on ice, using a pattern of 1.5 seconds of pulse followed by 10 seconds of
no pulse for a total of thirty pulses. The samples were centrifuged for 20 minutes at 4˚C
and a rate of 10,000rpm. The cell free extract was saved for purification.

Purification by Nickel Column
The nickel column was prepared by equilibrating with 15mL of equilibration
buffer (20mM Tris pH 7.4, 10mM imidazole, 300mM NaCl). 20uL of the cell free

extract was saved for gel analysis and the rest was loaded onto the column. The column
was washed with 20 column volumes of equilibration buffer and the first and last mL
fractions from the wash were collected. About 10 column volumes of elution buffer
(20mM Tris pH 7.4, 500mM imidazole) was run through the column, while collecting
1mL fractions of the elution. The column was washed with 10 more column volumes of
the elution buffer followed by 20 column volumes of equilibration buffer for storing.
The absorbance of each fraction was measured at 280nm to find the most concentrated
fractions. The selected fractions were analyzed by PAGE gel analysis.

Activity Assay
Into each of two cuvettes, 25mM sodium phosphate, 0.5mM allo-threonine,
0.01mM PLP and 800uL of water was added. 40uL of cell free extract, either induced
with 1% arabinose or uninduced, was added to each cuvette. The cuvettes were covered
and allowed to sit overnight at room temperature. The next day, the absorbance of each
cuvette was measured at 340nm immediately after the addition of 0.1mM NADH and
15U/mL of alcohol dehydrogenase. The absorbance at 340nm was collected for three
minutes. This was repeated for each cuvette.

Determination of Ammonium Sulfate Precipitation
Cell free extract was combined with various concentrations of ammonium sulfate
(AS); 30%, 45%, 55%, 65%, 75%, and 90%. The mixtures were centrifuged for 20
minutes at 4˚C at a rate of 10,000rpm to separate out the precipitates. A sample of
supernatant and pellet was removed and saved from each of the AS cuts. The samples

were run on gels for analysis. Three of the samples, 30%, 65%, and 75% cuts, were
tested for their activity using the same assay from above.

Fast Protein Liquid Chromatography (FPLC)
Cells were overexpressed with 1% arabinose and were purified by ammonium
sulfate precipitation. After a 30% cut, the 70% AS ppt was resuspeneded in 20mM Tris
pH 7.9 buffer. The FLPC column was stored in 50% water and 50% of 20% ethanol.
The column was washed with about 40 column volumes of water before use to remove
the ethanol, then it was equilibrated with the Tris buffer. Two pumps were connected to
the column; Pump A was 20mM Tris pH 7.9 and Pump B was 20mM Tris 1M NaCl pH
7.9. After the protein was injected onto the column, the FPLC ran a gradient of 100%
Pump A: 0% Pump B to 0% Pump A: 100% Pump B. 1mL fractions were collected and
their absorbance was measured at 280nm. The highest concentrated fractions were saved
for gel electrophoresis.

III. RESULTS
Overexpression

Overexpression conditions for SHMT were explored. It was assumed IPTG would
induce production of the protein. Numerous trials showed results similar to Figure 1.
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Figure 1: SDS-PAGE gel of cell free extract of SHMT SL75 BL21 cells with and without induction
using 1M IPTG. Lane contents: 1. 1mM IPTG, diluted; 2. 1 mM IPTG; 3. Protein standard; 4.
0mM IPTG, diluted; 5. 0mM IPTG; 6. 1mM IPTG, diluted; 7. 1mM IPTG; 8. 0mM IPTG, diluted;
9. 0mM IPTG; 10. 1mM IPTG; 11. 0mM IPTG. Lanes 1,2,4,5,10, and 11 were soluble fractions
and lanes 6 through 9 were insoluble.

No expression of SHMT was observed when using IPTG as the inducer. Numerous trials
were performed using arabinose instead of IPTG. In order to determine the ideal amount
of arabinose to use, an overexpression was performed using a range of arabinose
concentrations from 0% to 1% and can be seen in Figure 2.
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Figure 2: SDS-PAGE gel of cell free extract of SHMT SL75 BL21 cells induced with various
concentrations of arabinose. Lane contents: 1. 0% arabinose; 2. 0.002% arabinose; 3. 0.02%
arabinose; 4. 0.5% arabinose; 5. 1.0 % arabinose; 6. 0% arabinose; 7. 0.002% arabinose; 8. 0.02%
arabinose; 9. 0.5% arabinose; 10. 1.0% arabinose; 11. Protein standard

Low levels of overexpression are observed in lanes 4 and 5 with 0.5% and 1% arabinose,
respectively.

Purification
Protein purification by a nickel column was performed with the idea that the SHMT gene
on the plasmid in the E-coli cells also encodes for a his-tag. If this is the case, the his-tag
would allow for SHMT to stick to the nickel column as other protein washed through,
since histidine has a high affinity for metal ions such as nickel.
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Figure 3: SDS-PAGE gel of nickel column fractions from SHMT SL75 BL21 cells with and without
induction using 1% arabinose. Lane Contents: 1. Cell free extract; 2. Load; 3. First wash; 4. Last wash;
5. 2ndmL of elution; 6. 4thmL of elution; 7. Protein standard; 8. Cell free extract; 9. Concentrated
elution; 10. 2ndmL of elution; 11. 4thmL of elution; 12. Load; 13. First wash; 14. Last wash. Lanes 1-6
refer to the cells that were not induced with arabinose and Lanes 8-14 were induced with 1%.

Optimal results for the purification of SHMT by a nickel column would show only one
band of protein in the elution fraction, corresponding to SHMT. Multiple bands can be
seen in lane 10 so it was determined that purification by nickel column would not be used
to purify the protein from SHMT SL75 BL21 cells.

Activity Assay
Figure 4: Coupled reaction of SHMT and alcohol dehydrogenase (ADH).

The coupled reaction shown above will be used to observe the activity of SHMT. If
human SHMT actively converts allo-threonine to acetaldehyde, which is a known side
reaction catalyzed by SHMT from other sources, then the addition of NADH and alcohol
dehydrogenase (ADH) will oxidize NADH to NAD+. This can be measured by
absorbance spectroscopy because NADH absorbs at 340nm, whereas NAD+ does not.
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Figure 5: The activity of SHMT with allo-threonine observed by following the absorbance of NADH,
which is oxidized by ADH over time. SHMT SL75 BL21 cells had been overexpressed with 1%
arabinose. 40µL cell free extract was added to 500mM sodium phosphate, 33mM allo-threonine, 5mM
PLP, 50 mM NADH, 1500 u/mL ADH, and 800µL water. All the components except for NADH and
ADH were allowed to sit overnight. The absorbance was measured to be 1.41 after the addition of
50mM NADH and before the addition of ADH.

SHMT from several sources has been shown to catalyze the side reaction with allothreonine. Figure 5 shows that human SHMT is also capable of catalyzing the same
reaction.

Determination of Ammonium Sulfate Precipitation
In order to purify SHMT by salt precipitation, it’s important to know at which salt
concentration the protein will precipitate and salt out. A saturated ammonium sulfate
solution was added to cell free extract and cuts were made at 30%, 45%, 55%, 65%, 75%,
and 90% ammonium sulfate. The insoluble pellets as well as the soluble fractions were
run on a gel.
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Figure 6: SDS-PAGE gels of SHMT SL75 BL21 cells overexpressed with 1% arabinose and purified by
ammonium sulfate. Lane contents: (A) 1. Cell free extract; 2. Protein standard; 3. 30% pellet; 4. 45%
solution; 5. 45% pellet; 6. 45% pellet, diluted; 7. 55% solution. (B) 1. 55% pellet; 2. 65% pellet; 3. 65%
pellet, diluted; 4. 65% solution; 5. 75% solution; 6. 75% pellet; 7. Protein standard; 8. 75% pellet, diluted;
9. 95% solution.

The 30% AS pellet and the 65% and 75% AS solutions were saved for analysis by an
activity assay. The coupled reaction with alcohol dehydrogenase was used and the
absorbance of NADH at 340nm was measured over time for each fraction.
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Figure 7: Activity Assay for Protein Precipitation Fractions. 40µL of the ammonium sulfate
fractions were added to 500mM sodium phosphate, 33mM allo-threonine, 5mM PLP, 50 mM
NADH, 1500 u/mL ADH, and 800µL water.

Bef

ore alcohol dehydrogenase was added, the absorbances at 340nm were 0.550, 0.667, and
0.582 for the 30%, 65%, and 75% fractions, respectively. From this figure, it was
concluded that a 30% ammonium sulfate cut would remove unwanted proteins and a 70%
cut would contain SHMT.

Fast Protein Liquid Chromatography
SHMT SL75 BL21 cells were overexpressed with 1% arabinose and were purified by salt
precipitation. A 30% AS cut was made followed by a 70% cut. The precipitate from the
70% cut was resuspended in 20mM Tris buffer and was further purified by FPLC.
Fractions were collected from the FPLC and their absorbance was measured at 280nm.
Two peaks were observed where protein was eluted from the column, seen in Figure 8
below.

Figure 8: Absorbance of FPLC fractions at 280nm

Fractions 2, 3, 4, 25, 26, 27, 28, 29, and 35 from the FPLC run were analyzed by gel
electrophoresis shown in Figure 9 below.
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Figure 9: SDS-PAGE gel of SHMT SL75 BL21 cells induced with 1% arabinose and
purified by ammonium sulfate precipitation and FPLC. Lane Contents: 1. Fraction #2; 2. #3;
3. #4; 4. Protein standard; 5. #25; 6. #26; 7. #27; 8. #28; 9. #29; 10. #35.

The same fractions analyzed by gel electrophoresis were also analyzed using the activity
assay with allo-threonine which is presented below in Figure 10.
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Figure 10: The activity of SHMT with allo-threonine observed by following the absorbance of
NADH. 40µL of the FPLC fractions were added to 500mM sodium phosphate, 33mM
allothreonine, 5mM PLP, 50 mM NADH, 1500 u/mL ADH, and 800µL water.

A decrease in absorbance of NADH is not observed for any of the FPLC fractions
suggesting that SHMT was never eluted from the FPLC column.

IV. DISCUSSION
The goal of this experiment was to overexpress and purify human SHMT from E.
coli. SHMT was successfully overexpressed from SHMT SL75 BL21 cells using
arabinose as the inducer. Appropriate ammonium sulfate concentrations were
determined for the initial purification of the protein. In addition to this, the coupled side
reaction with allo-threonine was established, as it had not been studied using the human
enzyme.
Through multiple overexpression trials, it was observed that 1% arabinose
induces SHMT protein expression, whereas IPTG does not. It had been assumed that
IPTG would induce SHMT expression, but after analyzing SDS-PAGE results from
numerous overexpressions, similar to Figure 1, it was concluded that IPTG did not induce
SHMT expression. The molecular weight of human SHMT is approximately 53 kDa.
The protein standard used for gel electrophoresis has proteins with known molecular
weights of 113, 91, 49, 35.1, and 28.4 kDa. Looking at the protein standard in lane 3 of
Figure 1, the third band from the top of the gel corresponds to the protein that has a
molecular weight of 49 kDa. If SHMT was successfully overexpressed when using
IPTG, a band slightly above the 49 kDa marker would be seen in the lanes induced with
1mM IPTG and absent in control lanes that lacked IPTG. This is not observed in the
Figure 1 gel, suggesting that IPTG did not lead to the overexpression of SHMT.
Similar overexpressions were carried out using concentrations of arabinose in
place of IPTG and overexpression was observed. Through a trial that varied the
concentration of arabinose, it was concluded that a 1% arabinose concentration is
optimal. This can be observed in lanes 4 and 5 in Figure 2, which have concentrations of
0.5% and 1.0% arabinose, respectively. Looking at these lanes, there is a band that can

be seen around the predicted SHMT band location of approximately 50 kDa. This band
is absent in the lanes that either contained low concentrations of arabinose or lacked
arabinose, suggesting that a concentration of 0.5% or higher of arabinose will
overexpress human SHMT from the E. coli cells.
The cell free extract refers to the mixture that contains the proteins after insoluble
unwanted cell debris was removed. Looking at the gel in Figure 3, lane 1 is the cell free
extract from E. coli cells that were not induced with arabinose, and lane 8 is the cell free
extract from E. coli cells that were induced with 1% arabinose. A band that is slightly
above the 49kDa marker in lane 8 but which is absent in lane 1 further shows how 1%
arabinose successfully overexpresses the SHMT protein. For the nickel column
purification, both of the cell free extracts were loaded onto separate nickel columns. The
columns were washed with buffer to remove all the proteins that didn’t bind to the nickel.
Imidazole, a histidine analog, was used to elute the protein from the column and fractions
were collected. Lane 10 in Figure 3 is a fraction of the elution that was collected from
the nickel column, which had been loaded with the induced cell free extract. Ideally,
only one band would be seen in this lane corresponding to SHMT. However, lane 10
shows a few bands which suggests that purification of the protein from SHMT SL75
BL21 cells through nickel column is ineffective.
SHMT activity was observed when the coupled reaction assay, shown in Figure 4,
was performed using cell free extract from cells induced with 1% arabinose. Other
sources of SHMT have been shown to catalyze this side reaction, but the assay performed
in our laboratory is the first time that human SHMT has been shown to catalyze this side
reaction. The absorbance of NADH decreased over time after alcohol dehydrogenase was

added to the cuvette, as seen in Figure 5. It can be inferred from this graph that SHMT
actively converted allo-threonine to acetaldehyde. Also, before the addition of alcohol
dehydrogenase, the absorbance of the cuvette at 340nm read 1.41. Looking at the graph
when the absorbance was first collected, the absorbance reads only 0.71. This suggests
that in the few seconds after alcohol dehydrogenase was added and before the “start”
button was pressed, the alcohol dehydrogenase had already oxidized a large portion of the
NADH. This would need to be repeated using a control that was uninduced because if
the control also showed a decrease in the absorbance at 340nm, then it could be possible
that there is an E-coli enzyme that is capable of converting allo-threonine to
acetaldehyde. However, it is not possible to rule out the possibility that the observed
activity is due to another E-coli enzyme without a control.
From ammonium sulfate precipitation trials, it was concluded that for the optimal
purification of SHMT, a 30% ammonium sulfate cut would remove unwanted proteins
and a 70% cut would contain SHMT. Figure 6 shows the two gels from an ammonium
sulfate precipitation experiment. The desired SHMT band is not clearly noticeable in any
of the lanes until lane 6 of the second gel which is the 75% AS cut. The band might also
be seen in lane 4 of the same gel which is the 65% AS solution, but it’s difficult to see
here. To further determine the correct amount of ammonium sulfate needed to precipitate
SHMT from solution, an activity assay was performed using the 65% and 75% AS
solutions and the 30% AS pellet. The 30% pellet was used as a control in order to show
that very little or no SHMT is present in that particular cut. This is shown in Figure 7, as
the absorbance at 340nm for the 30% cut decreases very slightly and mostly stays
constant over time. The other two lines in this graph have a drastic decrease in

absorbance suggesting that there are high levels of SHMT in these fractions. From this
graph, it was determined that for the purification of SHMT, a 30% ammonium sulfate cut
would remove unwanted proteins and a 70% cut would contain SHMT.
The results from the FPLC indicate that SHMT was not further purified by this
technique. None of the fractions contained any trace of SHMT, as demonstrated by the
activity assay, suggesting that the protein was never successfully loaded onto the column.
The A280 of the FPLC fractions was measured in order to determine which fractions had
the highest protein concentration, assuming that at least one would contain SHMT.
Figure 8 has two strong peaks that show when protein was removed from the column. By
looking at this figure, it seems that the initial peak likely contains proteins that were
negatively charged and didn’t bind to the column. The second peak was assumed to
contain SHMT from when the protein was eluted from the column. Fractions involved in
these two peaks were saved for further analysis and were run on a gel. The gel in Figure
9 is difficult to see but it could be possible the lanes 2 or 6, fraction #3 and #26
respectively, show the SHMT band. To more accurately determine which fraction
contained SHMT, the coupled activity assay was performed. However, as seen in Figure
10, none of the fractions had a decrease in absorbance at 340nm. This suggests that none
of the fractions contained SHMT. There could be a few different explanations for this.
First, it’s possible that the SHMT eluted from the column was too dilute to show a
decrease in absorbance at 340nm. Second, there could have been a mistake during the
particular overexpression used for the FPLC column resulting in no SHMT be expressed.
Also, it’s very likely that this could be due to the operation of the pump or operator error
suggesting that the protein was never loaded onto the column. Troubleshooting along

with additional FPLC experiments should be done in order to obtain better results for the
purification of SHMT.

V. CONCLUSION
Despite the results from the FPLC, several accomplishments for the
overexpression and purification of human SHMT were met. First, arabinose was
identified as the inducer for the expression of SHMT instead of IPTG, and a 1%
arabinose concentration was determined to be optimal. In addition, appropriate
ammonium sulfate concentrations for the initial purification of SHMT were identified.
Finally, the coupled assay with allo-threonine was established, and it was demonstrated
that human SHMT can catalyze this side reaction.
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